TICAM2

TICAM2 (TRAM/TIRP) is a TIR domain-containing bridging adaptor that couples activated TLR4 to the downstream adaptor TICAM-1/TRIF, enabling IRF-3 activation and type I IFN-β induction during LPS signaling while having minimal capacity to activate NF-κB or the IFN-β promoter on its own (PMID:14519765). Structurally, its TIR domain docks onto the TLR4 TIR domain dimer through reciprocal BB-loop contacts (PMID:25306876), and TICAM2 then self-dimerizes to form a binding surface that recruits TICAM-1 via an acidic E87/D88/D89 interface (PMID:28630139). Correct subcellular positioning is required for this relay: N-terminal myristoylation anchors TICAM2 to membranes and a conserved acidic D91/E92 motif directs endosomal localization, which is essential for TLR4-driven type I IFN induction from the endosome; loss of D91/E92 redistributes the protein to the cytosol and abolishes autonomous self-aggregation while preserving its capacity to support IRF3 activation within assembled TLR4 complexes (PMID:26408662, PMID:28630139). Beyond canonical TLR4 signaling, TICAM2 acts as a node in an AKT-driven STING-TICAM2-IRF3-IDO1 signalosome during intracellular infection (PMID:30770800) and drives myeloid exhaustion programs—promoting LPS-induced neutrophil exhaustion through Src-family-kinase and STAT1 activation (PMID:32873853) and contributing to epigenetic exhaustion memory in monocytes after sepsis (PMID:39814939). TICAM2 expression is itself constrained by a SET8-ATF2-H4K20me1 axis acting at its promoter (PMID:32176860), and Ticam2 is the major-effect locus governing protective responses to SARS-CoV infection in mice (PMID:28592648).

1. 2003 High

   Established that TICAM2 is a dedicated bridging adaptor physically linking TLR4 to TRIF/TICAM-1, defining the MyD88-independent route to IRF-3 and IFN-β.

   Evidence Co-immunoprecipitation, overexpression, dominant-negative analysis and reporter assays in mammalian cells

   PMID:14519765

   Open questions at the time

   • Does not resolve the structural basis of the TLR4 or TRIF contacts
   • Does not address subcellular site of signaling
2. 2003 Medium

   Probed whether TICAM2 also feeds IL-1 receptor/NF-κB signaling, placing it upstream of IRAK/TRAF6/IKKβ in that branch.

   Evidence Co-immunoprecipitation with IL-1R and IRAK family members plus dominant-negative epistasis and NF-κB reporter assays, single lab

   PMID:12721283

   Open questions at the time

   • Relies on overexpression and dominant-negative panels rather than endogenous loss-of-function
   • Apparent NF-κB role conflicts with later finding of minimal autonomous NF-κB activation
3. 2014 High

   Defined the physical TLR4-TICAM2 interface, showing BB-loop residues of both TIR domains mediate the direct contact.

   Evidence Recombinant protein purification, in vitro GST pull-down, and BB-loop mutagenesis in both partners

   PMID:25306876

   Open questions at the time

   • In vitro reconstitution does not establish stoichiometry in cells
   • Does not show how the contact triggers downstream TRIF recruitment
4. 2015 High

   Resolved how TICAM2 is targeted to its signaling compartment, separating membrane anchoring (myristoylation) from endosomal localization (D91/E92) and showing localization is needed for autonomous activation.

   Evidence Site-directed mutagenesis, fractionation/imaging, and reporter assays in TICAM2-knockout reconstituted cells

   PMID:26408662

   Open questions at the time

   • Does not identify the machinery reading the D91/E92 motif
   • Does not define how localization couples to self-aggregation mechanistically
5. 2017 High

   Provided structural detail of the relay: TICAM2 dimerizes beneath the TLR4 TIR dimer and engages TICAM-1 through an acidic E87/D88/D89 motif at the endosome.

   Evidence NMR structural analysis with functional interface mapping and mutagenesis

   PMID:28630139

   Open questions at the time

   • No full-length complex structure
   • Dynamics of dimerization upon TLR4 engagement not captured
6. 2017 Medium

   Demonstrated organismal importance by showing Ticam2 is the major QTL governing protection against SARS-CoV pathogenesis.

   Evidence Ticam2 knockout mice, F2 QTL mapping, and SARS-CoV infection phenotyping

   PMID:28592648

   Open questions at the time

   • Does not define which downstream TICAM2 output confers protection
   • Single study in mouse strains
7. 2019 Medium

   Extended TICAM2 beyond TLR4 to an AKT-regulated STING-TICAM2-IRF3-IDO1 signalosome during Toxoplasma infection, acting TBK-independently.

   Evidence Phosphosite mutagenesis, β-catenin knockout cells, Co-IP, reporter assays, infection model

   PMID:30770800

   Open questions at the time

   • Direct AKT phosphorylation sites on TICAM2 not mapped to function
   • Generality beyond Toxoplasma not established
8. 2020 Medium

   Identified a TICAM2-dependent neutrophil exhaustion program driven by Src-family kinases and STAT1 during prolonged LPS challenge.

   Evidence TICAM2-knockout primary neutrophils, flow cytometry, Dasatinib epistasis, in vivo mucosal damage model

   PMID:32873853

   Open questions at the time

   • Direct link from TICAM2 to SFK activation not biochemically defined
   • Pharmacological inhibitor lacks SFK selectivity
9. 2020 Medium

   Showed TICAM2 expression is repressed by a SET8-ATF2-H4K20me1 axis at its promoter, linking chromatin regulation to TLR4-pathway output in microglia.

   Evidence ChIP, luciferase reporters, shRNA knockdown, overexpression, Co-IP in BV2 cells

   PMID:32176860

   Open questions at the time

   • Does not establish direct ATF2 binding versus indirect effects
   • Cell-type generality not tested
10. 2025 Medium

    Linked TICAM2 to durable epigenetic exhaustion memory, showing its ablation allows monocyte recovery and alters DNA methylation at immune-gene regulatory regions after sepsis.

    Evidence Ticam2 knockout mice, cecal slurry sepsis model, flow cytometry, genome-wide DNA methylation profiling

    PMID:39814939

    Open questions at the time

    • Causal chain from TICAM2 signaling to methylation changes unresolved
    • CEBPE-site methylation correlation not functionally validated

• How the endosomal TLR4 adaptor function of TICAM2 mechanistically connects to its roles in STING signaling and myeloid exhaustion/epigenetic memory remains unresolved.
• No unified mechanism linking adaptor activity to exhaustion programs
• No structure of TICAM2 in non-TLR4 complexes
• Direct post-translational modification sites controlling pathway choice undefined